×
About 832 results

ALLMedicine™ Oncology Treatment Center

Research & Reviews  343 results

How to Reduce the No-Show Rate in the Psychiatric Oncology Clinic: Clinical Safety and ...
https://doi.org/10.1176/appi.ps.201900480
Psychiatric Services (Washington, D.C.); Rashid A, Rickman K et. al.

Jan 20th, 2021 - Mental health stability among patients with cancer improves adherence to oncology treatment, contributing to better outcomes. In a comprehensive cancer center, the no-show rate for the psychiatric oncology clinic was higher than that of any other ...

Radiological assessment of response and adverse events associated with novel systemic o...
https://doi.org/10.1016/j.crad.2020.10.018
Clinical Radiology; Veerasuri S, Little D et. al.

Jan 11th, 2021 - The last decade has seen a paradigm shift in medical oncology treatment with the rise of novel systemic agents, principally molecular targeted therapy and immunotherapy. These new groups of anti-cancer treatment have revolutionised the prognostic ...

EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotyp...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786949
BMC Cancer; Joly-Tonetti N, Ondet T et. al.

Jan 6th, 2021 - Cutaneous adverse drug reactions (CADR) associated with oncology therapy involve 45-100% of patients receiving kinase inhibitors. Such adverse reactions may include skin inflammation, infection, pruritus and dryness, symptoms that can significantl...

see more →

Guidelines  31 results

KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and ...
https://doi.org/10.1016/j.kint.2020.06.046
Kidney International; Porta C, Bamias A et. al.

Oct 31st, 2020 - The association between kidney disease and cancer is multifaceted and complex. Persons with chronic kidney disease (CKD) have an increased incidence of cancer, and both cancer and cancer treatments can cause impaired kidney function. Renal issues ...

Investigating MET Exon 14 Mutations in Patients With NSCLC
https://www.targetedonc.com/view/investigating-met-exon-14-mutations-in-patients-with-nsclc

May 28th, 2020 - Mark M. Awad, MD, PhD, clinical director of the Thoracic Oncology Treatment Center at Dana-Farber Cancer Institute and assistant professor of Medicine at Harvard Medical School, discusses the characterization of patients with non–small cell lung c...

Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: Executive summary of an ASTRO Consensus Paper
https://www.practicalradonc.org/article/S1879-8500(18)30353-9/abstract
Wright,J.,et al

Jan 20th, 2019 - Standardization improves patient safety, efficiency, and accuracy in radiation oncology treatment. This consensus guidance represents an ASTRO quality initiative to provide recommendations for the standardization of normal tissue contouring perfor...

ASTRO Consensus Statement on Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: Executive Summary
https://www.astro.org/Patient-Care-and-Research/Clinical-Practice-Statements/Contouring-Consensus-Guidance-Document

Jan 20th, 2019 - This document provides tabled recommendations for normal tissues contouring during external beam treatment planning for each anotomical site in all definitive cases and those that should be considered in specific clinical scenarios. Additionally, ...

Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2720582
Foster,J.

Jan 10th, 2019 - Comparative analysis revealed CRS/HIPEC to be safe, often safer across the spectrum of NSQIP safety metrics when compared with similar-risk oncologic procedures. Patient selection was important in achieving observed outcomes. High complication rat...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  419 results

How to Reduce the No-Show Rate in the Psychiatric Oncology Clinic: Clinical Safety and ...
https://doi.org/10.1176/appi.ps.201900480
Psychiatric Services (Washington, D.C.); Rashid A, Rickman K et. al.

Jan 20th, 2021 - Mental health stability among patients with cancer improves adherence to oncology treatment, contributing to better outcomes. In a comprehensive cancer center, the no-show rate for the psychiatric oncology clinic was higher than that of any other ...

Radiological assessment of response and adverse events associated with novel systemic o...
https://doi.org/10.1016/j.crad.2020.10.018
Clinical Radiology; Veerasuri S, Little D et. al.

Jan 11th, 2021 - The last decade has seen a paradigm shift in medical oncology treatment with the rise of novel systemic agents, principally molecular targeted therapy and immunotherapy. These new groups of anti-cancer treatment have revolutionised the prognostic ...

EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotyp...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786949
BMC Cancer; Joly-Tonetti N, Ondet T et. al.

Jan 6th, 2021 - Cutaneous adverse drug reactions (CADR) associated with oncology therapy involve 45-100% of patients receiving kinase inhibitors. Such adverse reactions may include skin inflammation, infection, pruritus and dryness, symptoms that can significantl...

see more →

News  37 results

'Long-Running' Conspiracy: Cancer Center's Ex-Top Doc Indicted
https://www.staging.medscape.com/viewarticle/938197

Sep 27th, 2020 - William Harwin, MD, founder and former president of Florida Cancer Specialists, a large multisite practice, has been indicted by a federal grand jury for conspiring to restrict patient choice and allocate medical and radiation oncology treatment i...

'Long-Running' Conspiracy: Cancer Center's Ex-Top Doc Indicted
https://www.medscape.com/viewarticle/938197

Sep 27th, 2020 - William Harwin, MD, founder and former president of Florida Cancer Specialists, a large multisite practice, has been indicted by a federal grand jury for conspiring to restrict patient choice and allocate medical and radiation oncology treatment i...

Investigating MET Exon 14 Mutations in Patients With NSCLC
https://www.targetedonc.com/view/investigating-met-exon-14-mutations-in-patients-with-nsclc

May 28th, 2020 - Mark M. Awad, MD, PhD, clinical director of the Thoracic Oncology Treatment Center at Dana-Farber Cancer Institute and assistant professor of Medicine at Harvard Medical School, discusses the characterization of patients with non–small cell lung c...

Oncologists agree with AI treatment decisions about half the time
https://www.mdedge.com/fedprac/avaho/article/206866/breast-cancer/oncologists-agree-ai-treatment-decisions-about-half-time?channel=263
Will Pass

Aug 22nd, 2019 - When it comes to treatment recommendations for high-risk breast cancer, oncologists agree with a leading artificial intelligence platform about half the time, according to investigators. In the first study of its kind, involving 10 Chinese oncolog.

Electronic health records linked to lower patient safety
https://www.mdedge.com/fedprac/avaho/article/199676/practice-management/electronic-health-records-linked-lower-patient?channel=263
Caleb Rans

Apr 26th, 2019 - Higher reliance on electronic health records (EHRs) in ambulatory oncology practice was significantly associated with reduced safety actions among oncology nurses and prescribers, according to results of a statewide survey. “The purpose of this st.

see more →